Lv2
150 积分 2022-06-12 加入
T cell engagers in autoimmune diseases
1天前
待确认
A framework for building a synthetic cell from the SynCell Asia Initiative
9天前
已完结
Evolution of the psoriasis therapy landscape
14天前
已完结
A Mathematical Model to Investigate the Effects of Ceralasertib and Olaparib in Targeting the Cellular DNA Damage Response Pathway
14天前
已完结
Evolution of the psoriasis therapy landscape
20天前
已关闭
The present and future of bispecific antibodies for cancer therapy
29天前
已完结
Realizing the potential of agonistic antibody immunotherapy
1个月前
已完结
Two decades of PARP inhibitor synthetic lethality in cancer
1个月前
已完结
皖公网安备34019202002308
